Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Pfizer Sees Future Deals as China Biopharma Consolidates

publication date: Jan 21, 2010
To increase dealmaking in China, Pfizer has built a Shanghai-based business development team. On the one hand, the mega-pharma is looking forward to revenue growth in the China pharma market, while on the other hand it expects China’s famously fragmented pharmaceutical industry to begin a long-awaiting process of consolidation. For both reasons, China figures large in the company’s development plans for the next three to five years. More details...

Stock Symbol: (NYSE: PFE)


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital